Lamisil vs Tinactin

Lamisil
(OTC)
Tinactin
(OTC)
Lamisil is a fungal medication and a skin medication.
Tinactin is a skin medication.
Satisfaction Score
?
3.3
Moderately Satisfied
Satisfaction Score
?
4.0
Very Satisfied
Concern level
1.7
Concern level
1.3
Approval Date
+ -
December 30, 1992
Not Available
Number of discussions around the web Number of discussions + -
8,800 Discussions
2,894 Discussions
Taken For
+ -
Condition
Number of posts
#1 for Itching
#3 for Rash
#5 for Jock Itch
#8 for Fungal Nails
Lamisil is approved for Itching, Fungal Infection, Rash, Athlete's Foot, Jock Itch and Yeast Infection and is mostly mentioned together with these indications.
Condition
Number of posts
#1 for Itching
#3 for Jock Itch
#4 for Rash
#6 for Blisters
Tinactin is approved for Itching, Athlete's Foot, Jock Itch, Rash and Yeast Infection and is mostly mentioned together with these indications.
Side Effects and Concerns
+ -
Lam
Allergy
8
Eczema
6
Blisters
6
Liver Damage
5
Psoriasis
5
Hair Loss
4
Liver Disease
4
Tiredness
4
Bleeding
3
Peeling
3
Tin
Bleeding
5
Dry Skin
4
Skin Problems
3
Irritability
2
Discomfort
2
Diabetes
2
Bacterial Infection
2
Peeling
2
Tiredness
2
Anxiety
2
Compare concerns
By:
Lamisil
Lam
Tinactin
Tin
Allergy
Lam
Tin
8
0
Eczema
Lam
Tin
6
0
Blisters
Lam
Tin
6
0
Liver Damage
Lam
Tin
5
0
Psoriasis
Lam
Tin
5
0
Hair Loss
Lam
Tin
4
0
Liver Disease
Lam
Tin
4
0
Tiredness
Lam
Tin
4
2
Bleeding
Lam
Tin
3
5
Peeling
Lam
Tin
3
2
Bleeding
Tin
Lam
5
3
Dry Skin
Tin
Lam
4
0
Skin Problems
Tin
Lam
3
0
Irritability
Tin
Lam
2
0
Discomfort
Tin
Lam
2
0
Diabetes
Tin
Lam
2
0
Bacterial Infection
Tin
Lam
2
0
Peeling
Tin
Lam
2
3
Tiredness
Tin
Lam
2
4
Anxiety
Tin
Lam
2
0
Pregnancy Category (FDA) OpenClose all pregnancy categories
+ -
a b c d x n
Category A
Adequate and well-controllted studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
Category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category D
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Category N
FDA has not classified the drug.
close
B Category B
Before taking Lamisil during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
Not Available
Alcohol warning
+ -
There may be a negative interaction between Lamisil and alcohol.
There may be a negative interaction between Tinactin and alcohol.
Method of use
+ -
Ointment, Pill
Ointment, Spray
Dosages
+ -
Granules: 125 mg, 187.5 mg
Cream: 1%
Spray: 1%
Tablet: 250 mg
Aerosol: 1%
Cream: 1%
Packet: 1%
Powder: 1%
Solution: 1%
Spray: 1%
Food Instructions
+ -
No Food Instructions
No Food Instructions
Ingredients
+ -
Terbinafine
Tolnaftate
Drug Interactions
+ -
Interaction between Lamisil and Tinactin: Interaction not known, but may still exist. Always consult your doctor before taking these medications together. Do not stop taking the medications without a physician's advice.
Read more about:
Lamisil
Read more about:
Tinactin
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 119 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Please wait...